02138.HK
EC Healthcare
HKSE · Consumer Defensive · Household & Personal Products · HK
HKD 0.44
+6.10%Year over year
Reported trailing growth
- Revenue
- -2.2%
- EBITDA
- -26.6%
- EBIT
- +67.2%
- EPS
- —
- Free cash flow
- +38.9%
- Operating cash flow
- +4.0%
Forward estimates
Based on analyst estimates
- Revenue
- -76.6%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -0.9%
- EBITDA
- -11.4%
- EBIT
- -45.9%
- Net income
- —
- EPS
- —
- Free cash flow
- +45.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026